Binding of cystatin C to Alzheimer’s amyloid β inhibits in vitro amyloid fibril formation

[1]  V. Askanas,et al.  Cystatin C colocalizes with amyloid‐β and coimmunoprecipitates with amyloid‐β precursor protein in sporadic inclusion‐body myositis muscles , 2003 .

[2]  M. Mercken,et al.  Calpain Activity Regulates the Cell Surface Distribution of Amyloid Precursor Protein , 2002, The Journal of Biological Chemistry.

[3]  Katrina A B Goddard,et al.  A second locus for very-late-onset Alzheimer disease: a genome scan reveals linkage to 20p and epistasis between 20p and the amyloid precursor protein region. , 2002, American journal of human genetics.

[4]  W. Oertel,et al.  A polymorphism in the cystatin C promoter region is not associated with an increased risk of AD. , 2002, Neurology.

[5]  Pilar Latorre,et al.  Alzheimer’s disease and the cystatin C gene polymorphism: an association study , 2001, Neuroscience Letters.

[6]  J. Growdon,et al.  Elevation of cystatin C in susceptible neurons in Alzheimer's disease. , 2001, The American journal of pathology.

[7]  R. Nitsch,et al.  Increased Cystatin C in Astrocytes of Transgenic Mice Expressing the K670N-M671L Mutation of the Amyloid Precursor Protein and Deposition in Brain Amyloid Plaques , 2001, Neurobiology of Disease.

[8]  M. Oda,et al.  Lack of an association between cystatin C gene polymorphisms in Japanese patients with Alzheimer’s disease , 2001, Neurology.

[9]  G. Roks,et al.  The cystatin C polymorphism is not associated with early onset Alzheimer’s disease , 2001, Neurology.

[10]  B. Ghetti,et al.  Codeposition of Cystatin C with Amyloid‐β Protein in the Brain of Alzheimer Disease Patients , 2001, Journal of neuropathology and experimental neurology.

[11]  B T Hyman,et al.  Genetic association of a cystatin C gene polymorphism with late-onset Alzheimer disease. , 2000, Archives of neurology.

[12]  Philippe Taupin,et al.  FGF-2-Responsive Neural Stem Cell Proliferation Requires CCg, a Novel Autocrine/Paracrine Cofactor , 2000, Neuron.

[13]  M. Gold,et al.  A polymorphism in the cystatin C gene is a novel risk factor for late-onset Alzheimer’s disease , 2000, Neurology.

[14]  B. Ghetti,et al.  Codeposition of cystatin C with amyloid-ß protein in the brain of Alzheimer's disease patients , 2000, Neurobiology of Aging.

[15]  Bonnie F. Sloane,et al.  Differential Localization of Cysteine Protease Inhibitors and a Target Cysteine Protease, Cathepsin B, by Immuno-Confocal Microscopy , 1998, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[16]  M. Cadene,et al.  Instability of the Amyloidogenic Cystatin C Variant of Hereditary Cerebral Hemorrhage with Amyloidosis, Icelandic Type* , 1998, The Journal of Biological Chemistry.

[17]  O. Khorkova,et al.  α2-macroglobulin associates with β-amyloid peptide and prevents fibril formation , 1998 .

[18]  S. Paul,et al.  α2‐Macroglobulin Attenuates β‐Amyloid Peptide 1–40 Fibril Formation and Associated Neurotoxicity of Cultured Fetal Rat Cortical Neurons , 1998 .

[19]  K. Islam,et al.  Carboxyl-terminal fragments of beta-amyloid precursor protein bind to microtubules and the associated protein tau. , 1997, The American journal of pathology.

[20]  B. Margolis,et al.  The phosphotyrosine interaction domains of X11 and FE65 bind to distinct sites on the YENPTY motif of amyloid precursor protein , 1996, Molecular and cellular biology.

[21]  L. Walker,et al.  Cystatin C. Icelandic-like mutation in an animal model of cerebrovascular beta-amyloidosis. , 1996, Stroke.

[22]  I. Olafsson,et al.  The Molecular Pathology of Hereditary Cystatin C Amyloid Angiopathy Causing Brain Hemorrhage , 1996, Brain pathology.

[23]  R. Nixon,et al.  Properties of the endosomal-lysosomal system in the human central nervous system: disturbances mark most neurons in populations at risk to degenerate in Alzheimer's disease , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[24]  C. Graffagnino,et al.  Cystatin C mutation in an elderly man with sporadic amyloid angiopathy and intracerebral hemorrhage. , 1995, Stroke.

[25]  Anthony G. Spangenberger,et al.  Cystatin C, a protease inhibitor, in degenerating rat hippocampal neurons following transient forebrain ischemia , 1995, Brain Research.

[26]  E. Matsubara,et al.  Characterization of Apolipoprotein J-Alzheimer's Aβ Interaction (*) , 1995, The Journal of Biological Chemistry.

[27]  L. Lannfelt,et al.  Alpha 1-antichymotrypsin regulates Alzheimer beta-amyloid peptide fibril formation. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[28]  Jinhe Li,et al.  Gene expression and cellular content of cathepsin D in Alzheimer's disease brain: Evidence for early up-regulation of the endosomal-lysosomal system , 1995, Neuron.

[29]  R. Roos,et al.  Co‐localization of β/A4 and cystatin C in cortical blood vessels in Dutch, but not in Icelandic hereditary cerebral hemorrhage with amyloidosis , 1994, Acta neurologica Scandinavica.

[30]  M. E. Lewis,et al.  Aurintricarboxylic Acid Protects Hippocampal Neurons from NMDA‐and Ischemia‐Induced Toxicity In Vivo , 1993, Journal of neurochemistry.

[31]  P. Fraser,et al.  α1‐Antichymotrypsin Binding to Alzheimer Aβ Peptides Is Sequence Specific and Induces Fibril Disaggregation In Vitro , 1993 .

[32]  T. Miyatake,et al.  Cerebral amyloid angiopathy: A significant cause of cerebellar as well as lobar cerebral hemorrhage in the elderly , 1993, Journal of the Neurological Sciences.

[33]  B. Strooper,et al.  α2-macroglobulin expression in neuritic-type plaques in patients with Alzheimer's disease , 1993, Neurobiology of Aging.

[34]  C. Nitsch,et al.  The prolonged presence of glia-derived nexin, an endogenous protease inhibitor, in the hippocampus after ischemia-induced delayed neuronal death , 1992, Neuroscience.

[35]  A. Grubb,et al.  Human cystatin C, a cysteine proteinase inhibitor, inhibits bone resorption in vitro stimulated by parathyroid hormone and parathyroid hormone‐related peptide of malignancy , 1992, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[36]  M. Gensac,et al.  Cystatin C secretion by rat glomerular mesangial cells: autocrine loop for in vitro growth-promoting activity. , 1992, Biochemical and biophysical research communications.

[37]  G. Lynch,et al.  Inhibition of proteolysis protects hippocampal neurons from ischemia. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[38]  T. Akopyan.  Protein inhibitors of proteinases from brain , 1991, Neurochemical Research.

[39]  H. Vinters,et al.  Immunoreactive A4 and gamma-trace peptide colocalization in amyloidotic arteriolar lesions in brains of patients with Alzheimer's disease. , 1990, The American journal of pathology.

[40]  N. Yanagisawa,et al.  Immunohistochemical characterization of cerebrovascular amyloid in 46 autopsied cases using antibodies to beta protein and cystatin C. , 1990, Stroke.

[41]  C. López-Otín,et al.  Stroke in Icelandic patients with hereditary amyloid angiopathy is related to a mutation in the cystatin C gene, an inhibitor of cysteine proteases , 1989, The Journal of experimental medicine.

[42]  D. Selkoe,et al.  Immunochemical identification of the serine protease inhibitor α 1-antichymotrypsin in the brain amyloid deposits of Alzheimer's disease , 1988, Cell.

[43]  J. Ghiso,et al.  Constitutive secretion of cystatin C (gamma-trace) by monocytes and macrophages and its downregulation after stimulation , 1987, The Journal of experimental medicine.

[44]  K. Grzeschik,et al.  The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor , 1987, Nature.

[45]  J. Ghiso,et al.  Amyloid fibrils in hereditary cerebral hemorrhage with amyloidosis of Icelandic type is a variant of gamma-trace basic protein (cystatin C). , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[46]  C. Masters,et al.  Amyloid plaque core protein in Alzheimer disease and Down syndrome. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[47]  G. Glenner,et al.  Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein , 1984 .

[48]  B. Frangione,et al.  Amyloid fibril in hereditary cerebral hemorrhage with amyloidosis (HCHWA) is related to the gastroentero-pancreatic neuroendocrine protein, gamma trace , 1983, The Journal of experimental medicine.

[49]  A. Grubb,et al.  Human gamma-trace, a basic microprotein: amino acid sequence and presence in the adenohypophysis. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[50]  G. Thorbecke,et al.  Trace Proteins in Biological Fluids. IV. Physicochemical Properties and Sites of Formation of γ-Trace and β-Trace Proteins.∗ , 1967 .

[51]  M. Levine,et al.  Cystatins--inhibitors of cysteine proteinases. , 1992, Critical reviews in oral biology and medicine : an official publication of the American Association of Oral Biologists.

[52]  R. Kalaria,et al.  Alpha 1-antitrypsin and alpha 1-antichymotrypsin are in the lesions of Alzheimer's disease. , 1992, Neuroreport.

[53]  Q. Sun.  Growth stimulation of 3T3 fibroblasts by cystatin. , 1989, Experimental cell research.